| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.0091 | 0.9 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.024 | 0.9 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.042 | 0.9 |